Safety and immunogenicity of an HIV-1 tat toxoid vaccine in HIV-1 infected volunteers on highly active anti retroviral therapy (HAART)

被引：0
|
作者：
Frachette, MJ [1 ]
机构：
[1] Aventis Pasteur, F-69280 Marcy Letoile, France
来源：
RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES | 2003年
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：179 / 181
页数：3
相关论文
共 50 条
  • [31] HIV-1 Tat protein as a potential AIDS vaccine
    Goldstein, G
    NATURE MEDICINE, 1996, 2 (09) : 960 - 964
  • [32] Phenotypic patterns of HIV-1 clonal populations during highly active antiretroviral therapy (HAART)
    Favia, A
    Di Stefano, M
    Fiore, JR
    Pastore, G
    Angarano, G
    MICROBIOLOGICA, 1999, 22 (04): : 301 - 307
  • [33] Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It
    Steve, Runal John
    Alex, Diviya
    Yesudhason, Binesh Lal
    Prakash, John Antony Jude
    Mathews, Nitty Skari-ah
    Daniel, Dolly
    Ramalingam, Veena Vadhini
    Demosthenes, John Paul
    Ghale, Ben Chirag
    Anantharam, Raghavendran
    Rebekah, Grace
    Rupali, Priscilla
    Varghese, George Mannil
    Kannangai, Rajesh
    CURRENT HIV RESEARCH, 2021, 19 (03) : 277 - 285
  • [34] Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa
    Jaoko, Walter
    Karita, Etienne
    Kayitenkore, Kayitesi
    Omosa-Manyonyi, Gloria
    Allen, Susan
    Than, Soe
    Adams, Elizabeth M.
    Graham, Barney S.
    Koup, Richard A.
    Bailer, Robert T.
    Smith, Carol
    Dally, Len
    Farah, Bashir
    Anzala, Omu
    Muvunyi, Claude M.
    Bizimana, Jean
    Tarragona-Fiol, Tony
    Bergin, Philip J.
    Hayes, Peter
    Ho, Martin
    Loughran, Kelley
    Komaroff, Wendy
    Stevens, Gwynneth
    Thomson, Helen
    Boaz, Mark J.
    Cox, Josephine H.
    Schmidt, Claudia
    Gilmour, Jill
    Nabel, Gary J.
    Fast, Patricia
    Bwayo, Job
    PLOS ONE, 2010, 5 (09): : 1 - 16
  • [35] Gene therapy as a vaccine for HIV-1
    Berkhout, Ben
    Sanders, Rogier W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (10) : 1315 - 1321
  • [36] Cognitive safety of interruption of HAART in HIV-1 infection
    Childers, ME
    Woods, SP
    Letendre, S
    Mindt, MR
    McCutchan, JA
    Ellis, RJ
    NEUROLOGY, 2004, 62 (07) : A408 - A408
  • [37] UROLITHIASIS AMONG HIV INFECTED PATIENTS IN THE HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY (HAART) ERA
    Mirheydar, Hossein
    Raheem, Omer
    Palazzi-Churas, Kerrin
    Chenoweth, Marianne
    Lakin, Charles M.
    Sur, Roger L.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E907 - E908
  • [38] HIV-1 Tat vaccines
    Ensoli, B
    Cafaro, A
    VIRUS RESEARCH, 2002, 82 (1-2) : 91 - 101
  • [39] Tat and the HIV-1 promoter
    Jones, Katherine A.
    CURRENT OPINION IN CELL BIOLOGY, 1993, 5 (03) : 461 - 468
  • [40] Safety and immunogenicity of a multigene multiclade HIV-1 DNA plasmid vaccine boosted with heterologous HIV-1 MVA among healthy volunteers in Dar es Salaam, Tanzania
    Aboud, S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (08) : S1 - S1
12345